Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced NSCLC, BCC, CSCC, & as an adjuvant treatment for high-risk CSCC. Review Important Safety Info & Full Prescribing …

Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced non-small cell lung cancer (NSCLC). Review Important Safety Info & Full Prescribing Information including Med …

LIBTAYO as a single agent is indicated for the first-line treatment of adult patients with NSCLC whose tumors have high PD-L1 expression [Tumor Proportion Score (TPS) ≥ 50%] as …

LIBTAYO, an immunotherapy, may help with certain kinds of cancer. LIBTAYO is a treatment that works by blocking cancer cells from binding with PD-1. This enables T cells to detect cancer …

Patient examples from LIBTAYO trials Below are examples of 3 patients with locally advanced BCC previously treated with an HHI, who saw tumors shrink (partial response) with treatment. …

LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) that: Cannot be removed by surgery (locally advanced BCC) or when it has …

LIBTAYO (Lib-TIE-oh) is a prescription medicine used to treat adults with a type of lung cancer called non–small cell lung cancer (NSCLC). LIBTAYO may be right for adults with advanced …

How will I receive LIBTAYO? LIBTAYO is a medicine prescribed by a doctor. It is given in a hospital or clinic as a 30-minute intravenous (IV) infusion. That means it enters the body …

LIBTAYO was studied in a clinical trial that compared adult patients with advanced NSCLC who received LIBTAYO in combination with chemotherapy with those who received chemotherapy …

LIBTAYO tools for patients & caregivers LIBTAYO resources Get more information about LIBTAYO and how it may be an appropriate treatment option for your advanced NSCLC.